BCLI Brainstorm Cell Therapeutics Inc. logo

BCLI Brainstorm Cell Therapeutics Inc.

Healthcare
$0.68-4.64%ClosedMarket Cap: $7.5M

As of 2026-05-25

Insider Statistics (Q1 2025)

Acquisitions

11

Dispositions

0

Buy/Sell Ratio

0.00

Net Shares

+439,332

Shares Acquired

439,332

Shares Disposed

0

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Wed May 20Polverino Anthony J.directorSell150,000$0.70150,000
Wed May 20Naor NirdirectorSell180,000$0.70180,000
Wed May 20Lindborg StacydirectorSell150,000$0.70150,000
Wed May 20HARTOUNIAN HARTOUNdirectorSell225,000$0.70225,000
Wed May 20Dagher Ibrahim B.directorSell225,000$0.70225,000
Wed May 20Bairu MenghisteabdirectorSell150,000$0.70150,000
Tue Jan 07Dagher Ibrahim B.officer: Chief Medical OfficerSell50,000$0.0066,849
Tue Jan 07Dagher Ibrahim B.officer: Chief Medical OfficerSell80,000$1.730
Tue Jan 07Dagher Ibrahim B.officer: Chief Medical OfficerSell0$0.00315,742
Fri Jan 03Yablonka Uridirector, officer: EVP & Chief Business OfficerSell40,000$0.0048,464
Fri Jan 03Yablonka Uridirector, officer: EVP & Chief Business OfficerSell20,000$0.0068,464
Fri Jan 03Polverino Anthony J.directorSell24,000$0.0025,730
Fri Jan 03Lebovits Chaimofficer: President & CEOSell120,000$0.00200,960
Fri Jan 03FRENKEL JACOB AdirectorSell40,000$0.0043,777